Provided by Tiger Trade Technology Pte. Ltd.

Palatin

9.69
-0.5100-5.00%
Post-market: 9.690.00000.00%19:11 EDT
Volume:4K
Turnover:46.57K
Market Cap:17.17M
PE:-3.18
High:10.75
Open:10.63
Low:9.69
Close:10.20
52wk High:31.00
52wk Low:5.61
Shares:1.77M
Float Shares:1.39M
Volume Ratio:0.36
T/O Rate:0.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.0445
EPS(LYR):-32.1490
ROE:-297.24%
ROA:-65.26%
PB:1.62
PE(LYR):-0.30

Loading ...

Company Profile

Company Name:
Palatin
Exchange:
NASDAQ
Establishment Date:
1986
Employees:
29
Office Location:
11 Deer Park Drive,Suite 204,Monmouth Junction,New Jersey,United States
Zip Code:
08512
Fax:
- -
Introduction:
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that is in Phase 2 clinical trial for the treatment of inflammatory bowel diseases. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease, which is in Phase 3 clinical trial; and melanocortin peptides for diabetic retinopathy. Further, it is developing PL8177, an oral peptide formulation for treatment of ulcerative colitis, which entered Phase 2 clinical trials. Palatin Technologies, Inc. was founded in 1986 and is based in Cranbury, New Jersey.

Directors

Name
Position
Carl Spana
Chief Executive Officer and Director and President
John K.A. Prendergast
Director and Non-Executive Chairman of the Board
Stephen T. Wills
Chief Financial Officer and Chief Operating Officer and Executive Vice President and Secretary and Treasurer and Director
Alan W. Dunton
Director
Arlene M. Morris
Director

Shareholders

Name
Position
Carl Spana
Chief Executive Officer and Director and President
Stephen T. Wills
Chief Financial Officer and Chief Operating Officer and Executive Vice President and Secretary and Treasurer and Director